Daniel Thewlis is developing PCR software to optimize and accelerate the polymerase chain reaction (PCR) DNA analysis market, which is currently a $6 billion industry. His software aims to reduce PCR processing time by 50% through features that streamline workflows, improve connectivity and automation, and ensure data security and integrity. The development plan includes launching a digital test tube platform, designing a software engine, building a beta model, and proceeding to commercialization in August 2016 after pilot and refinement phases.